Drag a card by its title · ⚙ to size, swap or remove

The company

Immuneering Corporation

IMRX · Nasdaq

Health CareBiotechnologyNot moving yet

IMRX stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 23.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 41
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $541K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 108 (+22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7

Sale orders, 12 months0

Buyers · sellers6 · 0

Who	Did	Shares	Traded
Benjamin J. ZeskindPRESIDENT AND CEO	bought	2,400at $4.56	23 Jun 2026filed 24 Jun 2026
Brett Matthew HallCHIEF SCIENTIFIC OFFICER	bought	6,035at $4.15	15 Jun 2026filed 16 Jun 2026
Harold Eugene BrakewoodChief Business Officer	bought	5,250at $4.76	16 Jan 2026filed 21 Jan 2026
Brett Matthew HallCHIEF SCIENTIFIC OFFICER	bought	2,298at $4.57	15 Jan 2026filed 16 Jan 2026
Thomas J. SchallDirector	bought	21,645at $4.67	15 Jan 2026filed 20 Jan 2026
Leah R. NeufeldCHIEF PEOPLE OFFICER	bought	2,626at $4.15	13 Jan 2026filed 15 Jan 2026
Peter FeinbergDirector	bought	20,000at $4.35	12 Jan 2026filed 14 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders108+22 on the quarter

New · exited42 · 20

Reported value$160.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FMR LLCadded · filed 13 Aug 2026	9,704,610$48.4M	+6,672+0.1%
BlackRock, Inc.added · filed 7 Aug 2026	4,374,020$21.8M	+2,866,762+190.2%
Sanofiunchanged · filed 28 Jul 2026	2,708,559$13.5M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026	2,286,434$11.4M	+2,286,434
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,370,750$6.8M	+732,806+114.9%
STATE STREET CORPadded · filed 7 Aug 2026	1,001,995$5.0M	+733,475+273.2%
DCF Advisers, LLCadded · filed 10 Aug 2026	790,000$3.9M	+648,538+458.5%
MARSHALL WACE, LLPreduced · filed 13 Aug 2026	731,897$3.7M	-1,264,688−63.3%
Connor, Clark & Lunn Investment Management Ltd.added · filed 13 Aug 2026	601,255$3.0M	+200,892+50.2%
ALETHEA CAPITAL MANAGEMENT, LLCadded · filed 14 Aug 2026	472,935$2.4M	+450,000+1962.1%